These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38221865)
41. Antimicrobial resistance patterns in outpatient urinary tract infections--the constant need to revise prescribing habits. Bosch FJ; van Vuuren C; Joubert G S Afr Med J; 2011 May; 101(5):328-31. PubMed ID: 21837876 [TBL] [Abstract][Full Text] [Related]
42. Antibiotic Resistance Among Uropathogenic Kot B Pol J Microbiol; 2019 Dec; 68(4):403-415. PubMed ID: 31880885 [TBL] [Abstract][Full Text] [Related]
43. High antimicrobial resistance in urinary tract infections in male outpatients in routine laboratory data, Germany, 2015 to 2020. Salm J; Salm F; Arendarski P; Kramer TS Euro Surveill; 2022 Jul; 27(30):. PubMed ID: 35904060 [TBL] [Abstract][Full Text] [Related]
44. Non-Escherichia coli versus Escherichia coli community-acquired urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and outcome. Marcus N; Ashkenazi S; Yaari A; Samra Z; Livni G Pediatr Infect Dis J; 2005 Jul; 24(7):581-5. PubMed ID: 15998996 [TBL] [Abstract][Full Text] [Related]
45. [Changes in the antimicrobial susceptibility of Escherichia coli isolates from nosocomial versus community-acquired urinary tract infections]. Junquera S; Loza E; Baquero F Enferm Infecc Microbiol Clin; 2005 Apr; 23(4):197-201. PubMed ID: 15826543 [TBL] [Abstract][Full Text] [Related]
46. High rate of per oral mecillinam treatment failure in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli. Søraas A; Sundsfjord A; Jørgensen SB; Liestøl K; Jenum PA PLoS One; 2014; 9(1):e85889. PubMed ID: 24454943 [TBL] [Abstract][Full Text] [Related]
47. Acute uncomplicated UTI and E. coli resistance: implications for first-line empirical antibiotic therapy. Perfetto EM; Keating K; Merchant S; Nichols BR J Manag Care Pharm; 2004; 10(1):17-25. PubMed ID: 14720102 [TBL] [Abstract][Full Text] [Related]
48. Potential role of fosfomycin in the treatment of community-acquired lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Wilson DT; May DB Am J Ther; 2013; 20(6):685-90. PubMed ID: 21768870 [TBL] [Abstract][Full Text] [Related]
49. Factors associated with community-acquired urinary tract infections among adults attending assessment centre, Mulago Hospital Uganda. Kabugo D; Kizito S; Ashok DD; Graham KA; Nabimba R; Namunana S; Kabaka MR; Achan B; Najjuka FC Afr Health Sci; 2016 Dec; 16(4):1131-1142. PubMed ID: 28479906 [TBL] [Abstract][Full Text] [Related]
51. Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study. Abongomera G; Koller M; Musaazi J; Lamorde M; Kaelin M; Tasimwa HB; Eberhard N; Hongler J; Haller S; Kambugu A; Castelnuovo B; Fehr J BMC Infect Dis; 2021 Nov; 21(1):1179. PubMed ID: 34814849 [TBL] [Abstract][Full Text] [Related]
52. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. Kahlmeter G; J Antimicrob Chemother; 2003 Jan; 51(1):69-76. PubMed ID: 12493789 [TBL] [Abstract][Full Text] [Related]
53. [Current state of antibiotic resistance of pathogens causing community-acquired urinary tract infections in Russia, Belarus and Kazakhstan: results of the international multicenter study Darmis-2018]. Palagin IS; Sukhorukova MV; Dekhnich AV; Edelstein MV; Perepanova TS; Kozlov RS Urologiia; 2020 Mar; (1):19-31. PubMed ID: 32190999 [TBL] [Abstract][Full Text] [Related]
54. [Fosfomycin: an underrated antibiotic for urinary tract infections due to Escherichia coli]. Garau M; Latorre A; Alonso-Sanz M Enferm Infecc Microbiol Clin; 2001 Dec; 19(10):462-6. PubMed ID: 11844449 [TBL] [Abstract][Full Text] [Related]
55. Comparison of UTI antibiograms stratified by ED patient disposition. Grodin L; Conigliaro A; Lee SY; Rose M; Sinert R Am J Emerg Med; 2017 Sep; 35(9):1269-1275. PubMed ID: 28410918 [TBL] [Abstract][Full Text] [Related]
56. Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review. Stapleton AE; Wagenlehner FME; Mulgirigama A; Twynholm M Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32747356 [TBL] [Abstract][Full Text] [Related]
57. Escherichia coli and Klebsiella pneumoniae Sensitivity/Resistance Pattern Towards Antimicrobial Agents in Primary and Simple Urinary Tract Infection Patients Visiting University Hospital of Jamia Hamdard New Delhi. Rizwan M; Akhtar M; Najmi AK; Singh K Drug Res (Stuttg); 2018 Jul; 68(7):415-420. PubMed ID: 29529677 [TBL] [Abstract][Full Text] [Related]
58. Low frequency of antibiotic resistance among urine isolates of Escherichia coli in the community, despite a major hospital outbreak with Klebsiella pneumoniae producing CTX-M-15 in Uppsala County. Lindbäck H; Lindbäck J; Sylvan S; Melhus A Scand J Infect Dis; 2010 Apr; 42(4):243-8. PubMed ID: 20085420 [TBL] [Abstract][Full Text] [Related]
59. Changes in Antimicrobial Resistance of Urinary Tract Infections in Adult Patients over a 5-Year Period. Caskurlu H; Culpan M; Erol B; Turan T; Vahaboglu H; Caskurlu T Urol Int; 2020; 104(3-4):287-292. PubMed ID: 31940639 [TBL] [Abstract][Full Text] [Related]
60. Community-acquired urinary tract infections due to extended-spectrum β -lactamase-producing organisms in United Arab Emirates. Ranjan Dash N; Albataineh MT; Alhourani N; Khoudeir AM; Ghanim M; Wasim M; Mahmoud I Travel Med Infect Dis; 2018; 22():46-50. PubMed ID: 29409967 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]